Why the study?
Does long-term treatment with (n-3) fatty acids reduce serum triglycerides in patients with primary chylomicronemia?
Population
8 patients with primary chylomicronemia and severe familial hypertriglyceridemia
Design
Case_series
Follow-up
11 months of treatment
Authors
Loading...
May support TG reduction in primary chylomicronemia; hypothesis-generating case report needing controlled confirmation.
Does long-term treatment with (n-3) fatty acids reduce serum triglycerides in patients with primary chylomicronemia?
Long-term treatment with (n-3) fatty acids significantly reduces serum and VLDL triglycerides, plasma viscosity, and chylomicrons in patients with primary chylomicronemia, though it is associated with weight gain.
Pschierer et al. (1995) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: